Tokyo, Japan

Ono Shinichi

This inventor holds 1 USPTO granted patent. Top assignee: Nippharma Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ono Shinichi. Retrieved from https://idiyas.com/inventor/ono-shinichi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ono Shinichi

Introduction

Ono Shinichi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine through his innovative designs. His work primarily focuses on improving the delivery of powdered medicaments, which has the potential to enhance patient care.

Latest Patents

Ono Shinichi holds a patent for an inhaler designed specifically for powdered medicaments. This invention aims to provide a more efficient and effective method for patients to receive their medication. The inhaler is a testament to his commitment to advancing medical technology.

Career Highlights

Throughout his career, Ono has been associated with Nippharma Co., Ltd., where he has contributed to various projects aimed at improving pharmaceutical products. His dedication to innovation has earned him recognition in the industry.

Collaborations

[This section has been skipped.]

Conclusion

Ono Shinichi's work exemplifies the spirit of innovation in the medical field. His patent for an inhaler for powdered medicaments showcases his commitment to improving healthcare solutions. His contributions are valuable to both the industry and patients alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…